A. Parikh

Statistics

Publications

Citations

530

H-Index

Active since

2011

Affiliations

McMaster University(Current)

Medical University of Vienna

Western University

Takeda (United States)

University of California San Diego

A. Parikh is an author at McMaster University specializing in vedolizumab therapy, inflammatory bowel disease therapy, and inflammatory bowel disease.

Publications per year

2011–2015

Publications

Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

Maria Rosario, Nathanael L. Dirks, Marc R. Gastonguay et al. · Alimentary Pharmacology & Therapeutics · 2015 · 258 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

Debashish Bose, Lisa J. Zimmerman, Mariaelena Pierobon et al. · British Journal of Cancer · 2011 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +15

DOP058 Pharmacokinetic and pharmacodynamic relationship and immunogenicity of vedolizumab in adults with inflammatory bowel disease: Additional results from the GEMINI 1 and 2 studies

M. Rosario, T. Wyant, Catherine Milch et al. · Journal of Crohn s and Colitis · 2014 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

P497 Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6

W. Sandborn, Brian G. Feagan, Walter Reinisch et al. · Journal of Crohn s and Colitis · 2014 · 13 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

1–5 of 5